🔎 Trials Near Me

Domov › Burkitov lymfóm › Pennsylvania › Philadelphia

Klinické štúdie Burkitov lymfóm v meste Philadelphia, PA

16 štúdií pre Burkitov lymfóm hľadá účastníkov v zariadeniach v meste Philadelphia a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.

Oficiálny text štúdie (anglicky)

Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Prebieha náborFáza 3
  • Children's Hospital of Philadelphia (Data Collection Only), Philadelphia
Vek 1 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT07223021

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Prebieha náborFáza 1
  • Children's Hospital of Philadelphia, Philadelphia
Vek 0 až 18 · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT06173518

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Prebieha náborFáza 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 míľ odtiaľ
366 Days – 46 Years · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Prebieha náborFáza 3
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Vek 18 až 39 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT03150693

Blinatumomab Consolidation in Real World

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
  • University of Pennsylvania, Philadelphia
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07117136

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Prebieha náborObservačná štúdia
  • Children's Hospital of Philadelphia, Philadelphia
Vek 0 až 38 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Prebieha náborFáza 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 míľ odtiaľ
365 Days · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Prebieha náborFáza 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
6 Months – 25 Years · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Prebieha náborFáza 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 míľ odtiaľ
Vek 1 až 30 · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Prebieha náborFáza 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 míľ odtiaľ
365 Days – 25 Years · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Prebieha náborFáza 2
  • Children's Hospital of Philadelphia, Philadelphia
Vek 7 až 25 · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT05082519

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Prebieha nábor
  • Children's Hospital of Philadelphia, Philadelphia
Do veku 25 · Všetky pohlavia · Aktualizované 8. 7. 2026 · NCT03810196

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

Prebieha náborFáza 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Vek 0 až 29 · Všetky pohlavia · Aktualizované 26. 5. 2026 · NCT05480449

Co-administration of CART22-65s and huCART19 for B-ALL

Prebieha náborFáza 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Do veku 29 · Všetky pohlavia · Aktualizované 27. 3. 2026 · NCT05674175

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Prebieha náborFáza 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Vek 15 až 50 · Všetky pohlavia · Aktualizované 9. 9. 2025 · NCT04150497

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Prebieha náborFáza 2
  • Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington · 25 míľ odtiaľ
Vek 1 až 25 · Všetky pohlavia · Aktualizované 4. 5. 2025 · NCT03509961

Štúdie Burkitov lymfóm v iných mestách

Iné štúdie v Philadelphia

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.